Registry collecting radiological data on pancreatic cancer
Official title: Radiology Registry on Pancreatic Malignancies
Run by IRCCS San Raffaele · NCT05714111 · Data updated 2026-11-12
This study is collecting medical imaging data from patients with pancreatic cancer to see how their condition progresses and how well they respond to treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1300 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | March 4, 2022 |
| Main results expected | March 30, 2027 |
| Study ends | March 30, 2030 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT05714111 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are suspected of or diagnosed with pancreatic cancer at any stage.
✕Probably not a fit
Patients with non-primary pancreatic diseases will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather both retrospective and prospective radiological data to evaluate the malignancy and prognosis of pancreatic diseases. Conducted at a single center, it will track clinical outcomes such as progression-free survival and overall survival for patients diagnosed with pancreatic neoplasms. Data collection will span from 2014 to 2027, with a maximum follow-up of three years per patient, and will involve multidisciplinary discussions for treatment planning.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of pancreatic malignancies and improve patient prognostication and treatment strategies.
How similar studies have gone: Other studies have shown success in utilizing radiological data to assess cancer prognosis, making this approach promising yet still requiring further validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age * Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage. * able and willing to sign informed consent Exclusion Criteria: * Patients with non-primary pancreatic disease
Where it's running
-
Department of Radiology, IRCCS Ospedale San Raffaele
Milan, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Analyzing factors affecting pancreatic tumors and cysts
This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.
-
Liquid biopsy biomarkers to detect and monitor pancreatic cancer
Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.
-
Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
-
Using technology to improve care for pancreatic cancer patients
This study is trying to see if sharing patient data among hospitals can help improve care and outcomes for people with pancreatic cancer.
-
Assessing survival and quality of life in patients with advanced pancreatic cancer
This study looks at how long people with advanced pancreatic cancer live and how their quality of life is affected while being treated at different hospitals in the Nordic region.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.